Skip to main
AMTX
AMTX logo

Aemetis (AMTX) Stock Forecast & Price Target

Aemetis (AMTX) Analyst Ratings

Based on 3 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Aemetis Inc. has shown a significant improvement in its India operations, with revenues increasing from $3 million in Q1 2025 to $12 million in Q2 2025, indicative of strong market demand and effective management strategies. The company's ability to secure new contracts is expected to further enhance its revenue potential in Q3 and Q4, contributing positively to its overall growth trajectory. Additionally, Aemetis's current valuation appears attractive when analyzed through a net present value assessment, suggesting considerable upside potential based on the company's operational advancements and market positioning.

Bears say

Aemetis Inc reported weaker-than-expected financial results for Q2 of fiscal 2025, with an earnings per share (EPS) of $(0.41) falling short of both internal estimates and consensus expectations. Furthermore, projections for the company's 2025 revenue have been revised down to $270 million, reflecting a decrease from the previous estimate of $280 million. This ongoing trend of underperformance and reduced revenue outlook contributes to a negative assessment of the company's financial health.

Aemetis (AMTX) has been analyzed by 3 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aemetis and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aemetis (AMTX) Forecast

Analysts have given Aemetis (AMTX) a Strong Buy based on their latest research and market trends.

According to 3 analysts, Aemetis (AMTX) has a Strong Buy consensus rating as of Nov 25, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aemetis (AMTX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.